ST SaiLong: Subsidiary Hunan SaiLong and Changsha SaiLong resume work and production
*ST SaiLong announced that its wholly-owned subsidiary Hunan SaiLong Pharmaceutical Co., Ltd. and Hunan SaiLong Pharmaceutical Co., Ltd. will officially resume work and production on September 1, 2025. Previously, these two companies conducted systematic maintenance work during high-temperature periods
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments